title: Comments on "Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patients".
authors.forename: Horst F
authors.initials: HF
authors.lastname: Schran
authors.forename: Douglas F
authors.initials: DF
authors.lastname: Hager
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001682:Biological Availability; D002276:Carcinoid Tumor / Q000188:drug therapy* / Q000378:metabolism; D016903:Drug Monitoring; D006801:Humans; D018358:Neuroendocrine Tumors / Q000188:drug therapy* / Q000378:metabolism; D015282:Octreotide / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012107:Research Design; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide